Allard C

ORCID: 0000-0002-8829-4984 · 2 papers in corpus · active 2023-2026
2026
A phase I study to evaluate the dosimetry and safety of [89Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis.
European journal of nuclear medicine and molecular imaging ·doi:10.1007/s00259-026-07853-y

PURPOSE: Misfolded superoxide dismutase-1 (mSOD1) is an abnormal protein observed in amyotrophic lateral sclerosis (ALS) and constitutes a therapeutic target. The present study evaluated the biodistribution, dosimetry, and safety of a new a…

2023
Genetic effects on the timing of parturition and links to fetal birth weight.
Nature genetics ·doi:10.1038/s41588-023-01343-9

The timing of parturition is crucial for neonatal survival and infant health. Yet, its genetic basis remains largely unresolved. We present a maternal genome-wide meta-analysis of gestational duration (n = 195,555), identifying 22 associate…